SCHEMBL1106855

SCHEMBL1106855

Cc1cccc(OCc2ccc(/C=C/[N+](=O)O)cc2)n1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOA P21397 6/20 0.41
MAOB P27338 6/20 0.41
GABRA5 P31644 1/20 0.39
TLR4 O00206 6/20 0.38
TLR2 O60603 6/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
ADAMTS4 O75173 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
GBA1 P04062 1/20 0.34
HSD17B3 P37058 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL509706 0.88 MAOA (0.55) MAOAMAOBTLR4TLR2NPC1
SCHEMBL509705 0.88 MAOA (0.55) MAOAMAOBTLR4TLR2NPC1
SCHEMBL15177161 0.81 GABRA5 (0.44) MAOAMAOBGABRA5NPC1RAB9A
SCHEMBL10245554 0.81 NPC1 (0.46) MAOAMAOBGABRA5TLR4TLR2
SCHEMBL509670 0.80 MAOA (0.48) MAOAMAOBGABRA5NPC1RAB9A
SCHEMBL10245287 0.78 GABRA5 (0.41) GABRA5NPC1RAB9AADAMTS4MAPT
SCHEMBL15196489 0.77 GABRA5 (0.42) MAOAMAOBGABRA5ADAMTS4MAPT
SCHEMBL10245208 0.74 TLR4 (0.44) MAOAMAOBTLR4TLR2MEN1
SCHEMBL6120364 0.73 RXRA (0.55) NPC1RAB9ASMN1; SMN2
SCHEMBL1563576 0.73 GABRA5 (0.55) MAOBGABRA5MAPTSMN1; SMN2GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841327-B2 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2014-09-23 US disclosed
US-8158657-B2 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-04-17 US disclosed
US-8153662-B2 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-04-10 US disclosed
US-20120029023-A1 HETEROCYCLES SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING THEREOF TANAKA KEIGO (JP) 2012-02-02 US disclosed
US-20100168173-A1 HETEROCYCLES SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING THEREOF TANAKA KEIGO 2010-07-01 US disclosed
US-20100160379-A1 HETEROCYCLES SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING THEREOF TANAKA KEIGO 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168173-A1 HETEROCYCLES SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING THEREOF ERG28, CBR3, CBR1 MAOA 1006/4885MAOB 800/4885GABRA5 2828/4885
US-20120029023-A1 HETEROCYCLES SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING THEREOF CYP4X1, ERG28, CYP51A1 MAOA 596/4885MAOB 568/4885GABRA5 2329/4885
US-20100160379-A1 HETEROCYCLES SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING THEREOF ERG28, CBR3, CBR1 MAOA 1006/4885MAOB 800/4885GABRA5 2828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.